A Journey in Science: Immersion in the search for effective cancer immunotherapies | Molecular Medicine | Full Text
NCI's Steven Rosenberg Wins Service to America Medal - NCI
Using your own immune system to fight cancer | NIH MedlinePlus Magazine
Surgery Branch (@NCI_CCR_SB) / Twitter
Life Science Technology Visionary Steve Rosenberg Joins Anju Software's Board of Directors | Business Wire
How Immunotherapy Is Fighting Cancer in Clinical Trials | Time
NCI's Rosenberg Wins Szent-Györgyi Prize - NCI
Lion Biotech: Tumor Infiltrating Lymphocyte Therapy Could Be Paradigm Shift For Treatment Of Melanoma And Other Solid Tumors (NASDAQ:IOVA) | Seeking Alpha
Dr. Steven Rosenberg receives the 2018 ACS Jacobson Innovation Award | The Bulletin
Setting the Body's 'Serial Killers' Loose on Cancer - The New York Times
STEVEN ROSENBERG | Mount Sinai - New York
Clinical trial gives breast cancer patient a second chance | NIH MedlinePlus Magazine
Dr. Steven Rosenberg – Immunotherapy Pioneer - The Friends of Patients at the NIH
uMotif evolves leadership team with appointment of Steve Rosenberg as CEO | World Pharma Today
Steven A. Rosenberg, M.D., Ph.D. | NIH Intramural Research Program
Life Science Technology Visionary Steve Rosenberg Joins Anju Software's Board of Directors | Business Wire
Steven A. Rosenberg Works to Unmask Cancer's Achilles Heel - The ASCO Post
Driving gene-engineered T cell immunotherapy of cancer | Cell Research
Dr. Steven A. Rosenberg, Winner of the 2020 Lloyd J. Old Award - Cancer Research Institute (CRI)
Life Science Technology Visionary Steve Rosenberg Joins Anju Software's Board of Directors
Steven A. Rosenberg, M.D., Ph.D. | NIH Intramural Research Program
Steven Rosenberg Receives Szent-Györgyi Prize, FDA Names Elizabeth Jungman Head of Regulatory Policy, and more | ASH Clinical News | American Society of Hematology
Steven Rosenberg - Wikipedia
Setting the Body's 'Serial Killers' Loose on Cancer - The New York Times
Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits - The New York Times
How working Christmas Eve in the hospital became this family's tradition | Lewis Katz School of Medicine at Temple University
National Cancer Institute - NCI's Dr. Steven Rosenberg is leading a new clinical trial for some patients with melanoma. The study is testing dendritic cell vaccines, as this summary explains: https://ccr.cancer.gov/news/article/novel-technique-used-to ...
uMotif Adds eClinical Industry Veteran Steve Rosenberg to Board of Directors - uMotif
Completed TCR clinical trials | Download Table
